Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Triphenylphosphine oxide is a potent and selective inhibitor of the transient receptor potential melastatin-5 ion channel.
Palmer RK, Atwal K, Bakaj I, Carlucci-Derbyshire S, Buber MT, Cerne R, Cortés RY, Devantier HR, Jorgensen V, Pawlyk A, Lee SP, Sprous DG, Zhang Z, Bryant R. Palmer RK, et al. Among authors: Cortes RY. Assay Drug Dev Technol. 2010 Dec;8(6):703-13. doi: 10.1089/adt.2010.0334. Assay Drug Dev Technol. 2010. PMID: 21158685
Thymol and related alkyl phenols activate the hTRPA1 channel.
Lee SP, Buber MT, Yang Q, Cerne R, Cortés RY, Sprous DG, Bryant RW. Lee SP, et al. Among authors: Cortes RY. Br J Pharmacol. 2008 Apr;153(8):1739-49. doi: 10.1038/bjp.2008.85. Epub 2008 Mar 10. Br J Pharmacol. 2008. PMID: 18334983 Free PMC article.
ASCL1 regulates the expression of the CHRNA5/A3/B4 lung cancer susceptibility locus.
Improgo MR, Schlichting NA, Cortes RY, Zhao-Shea R, Tapper AR, Gardner PD. Improgo MR, et al. Among authors: Cortes RY. Mol Cancer Res. 2010 Feb;8(2):194-203. doi: 10.1158/1541-7786.MCR-09-0185. Epub 2010 Feb 2. Mol Cancer Res. 2010. PMID: 20124469 Free PMC article.